华法林治疗动脉粥样硬化性心血管疾病极高危病例84例临床观察  

Treatment of extremely high risk of atherosclerotic cardiovascular disease with warfarin:84 cases report

作　　者：张靖[1] 徐亦农 季猛[1] 孙吉林[1] 张闻闻[1] 张发[1] Zhang ring;Xu Yinong;Ji Meng;Sun Jilin;Zhang Wenwen;Zhang Fa(The Fourth People's Hospital of Taizhou,Taizhou 225300,China)

机构地区：[1]江苏省泰州市第四人民医院,225300

出　　处：《中国实用医刊》2018年第23期112-114,共3页Chinese Journal of Practical Medicine

摘　　要：目的观察华法林治疗动脉粥样硬化性心血管疾病(ASCVD)极高危病例的临床效果。方法对2010年12月至2018年3月泰州市第四人民医院应用华法林治疗的84例ASCVD相关的极高危病例的临床资料进行回顾性分析。结果84例患者均未发生新的缺血性事件,病情均得到改善和控制;华法林的抗凝作用、以及可能的解除血管痉挛和影响血流动力学的作用,对脑小血管病是有益的。结论门诊华法林抗凝治疗ASCVD极高危病例是安全有效的。Objective To observe the clinical effects of warfarin on extremely high risk cases of atherosclerotic cardiovascular disease ( ASCVD ) . Methods The clinical data of 84 ASCVD related high-risk patients which were treated with warfarin in the Fourth People ' s Hospital of Taizhou from December 2010 to March 2018 were retrospectively analyzed. Results All these 84 cases had no new ischemic events, no seizures or development, and their condition was improved and controlled; the anticoagulant effect of warfarin and its possible effect on relieving vasospasm, and its influence on hemodynamics were beneficial to cerebellar small vessel disease. Conclusions Warfarin anticoagulation therapy is effective and safe in the treatment of very high risk cases of ASCVD.

关 键 词：动脉粥样硬化 心血管疾病 抗凝 华法林 

分 类 号：R54[医药卫生—心血管疾病]